Short answer
BrightSpring Health Services, Inc. (BTSG) filed an 8-K current report with the SEC on July 31, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results for quarter ended June 30, 2026.
BrightSpring Health Services, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026
- Press release furnished as Exhibit 99.1 contains financial results and management commentary
- Investors should review Exhibit 99.1 for revenue, earnings, guidance, and operating metrics
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $3,873M, up 23%, while Adjusted EBITDA $206M rose 44.2%; operating leverage strengthened materially
- Net income from continuing operations $87M versus $9M, with diluted EPS $0.39 versus $0.04
- Pharmacy revenue grew 22% as revenue per prescription rose 22%; Provider Services revenue increased 30%
- $300M debt paydown reduced leverage to 2.15x from 2.27x and generated interest savings
- 2026 guidance increased to revenue $15,100M–$15,425M and Adjusted EBITDA $820M–$845M, excluding future acquisitions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other BrightSpring Health Services, Inc. 8-K filings
Get the next BTSG 8-K as it lands
Follow BTSG for push alerts, or ask the research agent what this filing means.